Star Therapeutics Raises $125M Series D Round

Star Therapeutics Raises $125M Series D Round Back to Home Tweet SOUTH SAN FRANCISCO, CA, Star Therapeutics has announced an oversubscribed $125 million Series D financing. Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other diseases, has announced an oversubscribed $125 million Series D financing. The financing round was co-led by Sanofi Ventures and Viking Global Investors with participation from both existing ...